Brivomax-100 Tablets

Brivomax-100 Brivaracetam 100 mg Tablets

Brivomax-100 Tablets contain Brivaracetam 100 mg, an antiepileptic medicine used in the management of partial-onset seizures associated with epilepsy.

Brivaracetam belongs to the antiepileptic class of medicines and is available as an oral tablet formulation. It may be prescribed as monotherapy or as adjunctive therapy depending on the patient's clinical condition and the treating physician's assessment. 

What Are Brivomax-100 Tablets Used For?

Brivomax-100 Tablets are used for the treatment of partial-onset seizures in patients with epilepsy.

Partial-onset seizures originate in a specific area of the brain and may present with different symptoms depending on the region involved. Appropriate antiepileptic treatment is selected according to the patient's seizure type, medical history and response to therapy.

Brivaracetam is specifically indicated for the treatment of partial-onset seizures. 

Uses of Brivomax-100

Brivomax-100 may be used for:

• Partial-onset seizures

• Epilepsy associated with partial-onset seizures

• Seizure management requiring Brivaracetam therapy

• Adjunctive treatment of partial-onset seizures where prescribed by a qualified healthcare professional

Partial-Onset Seizures

Partial-onset seizures, also known as focal seizures, begin in a specific region of the brain. Their clinical presentation can vary from one person to another.

Brivaracetam is used to help control partial-onset seizures as part of an appropriate epilepsy treatment plan. 

How Does Brivomax-100 Work?

Brivomax-100 contains Brivaracetam, which acts primarily by binding to synaptic vesicle protein 2A (SV2A) in the brain.

This mechanism is associated with modulation of neurotransmitter release and contributes to the antiepileptic activity of Brivaracetam.

The medicine is prescribed to help reduce the occurrence of partial-onset seizures. 

Role in Epilepsy Management

Epilepsy is a neurological disorder characterized by a tendency to experience recurrent seizures.

Treatment is selected according to seizure type, age, medical history, concurrent medicines and individual response.

Brivaracetam is specifically used for partial-onset seizures and may be used alone or together with other antiepileptic medicines according to medical advice. 

Product Information

Brand Name: Brivomax-100

Composition: Brivaracetam Tablets 100 mg

Active Ingredient: Brivaracetam

Dosage Form: Tablets

Strength: 100 mg

Route of Administration: Oral

Therapeutic Class: Antiepileptic / Anticonvulsant

Therapeutic Area: Neurology

Primary Indication: Partial-Onset Seizures

Packing: 10 x 10 Tablets

Key Product Features

• Contains Brivaracetam 100 mg

• Antiepileptic tablet formulation

• Used in the management of partial-onset seizures

• Relevant to epilepsy treatment

• Oral tablet dosage form

• 100 mg strength

• 10 x 10 tablet packing

Important Information

Brivomax-100 is a prescription medicine and should be used only according to the advice of a qualified healthcare professional.

The dosage should be individualized according to the patient's age, clinical response, tolerability and other relevant medical factors.

Brivaracetam can be used as monotherapy or adjunctive therapy according to the prescribed treatment plan. 

Patients should not change the dose, stop treatment or alter the treatment schedule without consulting their healthcare professional.

Patients should inform their healthcare professional about all medicines they are taking and any existing medical conditions before starting treatment.

Brivaracetam may cause central nervous system-related adverse effects such as somnolence, dizziness, fatigue or other effects that may affect alertness. Patients should follow appropriate medical advice regarding activities requiring mental alertness.

Storage

Store the product according to the storage conditions specified on the approved product label.

Keep the medicine out of reach of children.

Product Summary

Brivomax-100 Tablets contain Brivaracetam 100 mg, an antiepileptic medicine used for the treatment of partial-onset seizures associated with epilepsy.

Brivaracetam acts primarily through binding to synaptic vesicle protein 2A (SV2A), a mechanism associated with its anticonvulsant activity. 

The medicine should be used according to the prescribing information and under the supervision of a qualified healthcare professional.